Inhibition of tumor necrosis factor-alpha release during endotoxic shock by ozone oxidative preconditioning in mice

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 12, 2004, Pages 906-909

  Zamora, Zullyt B ^a,d   Borrego, Aluet ^a   López, Orlay Y ^b   Delgado, René ^b   Menéndez, Silvia ^a   Schulz, Siegfried ^c   Hernández, Frank ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

^b Center of Pharmaceutical Chemistry Cuba   (Cuba)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d Ozone Research Center Havana   (Cuba)

Author keywords

Endotoxic shock, mouse; Ozone oxidative preconditioning; Tumor necrosis factor alpha

Indexed keywords

DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; OZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; OXYGEN THERAPY; PROTEIN SECRETION; SEPTIC SHOCK;

EID: 10644230912     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297047     Document Type: Article

References (26)

1. Deitsch, E. A., Multiple organ failure: pathophysiology and potential future therapy. Ann. Surg. 216, 117 (1992)
2. Remick, D. G., Strieter, R. M., Eskandari, M. K., Role of tumor necrosis factor-alpha in lipopolisaccharide-induced pathologic alterations. Am. J. Pathol. 136, 49 (1990)
3. Szabó, C., Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 3, 1305 (1995)
4. Novelli, G. P., Role of free radicals in septic shock. J. Physiol. Pharmacol. 4, 517 (1997)
5. Newton, R. C., Decicco, C. P., Therapeutical potential and strategies for inhibiting tumor necrosis factor-alpha. J. Med. Chem. 47, 334 (1999)
6. Billiar, T. R., Nitric oxide. Novel biology with clinical relevance. Ann. Surg. 221, 339 (1995)
7. Jakab, G. J., Spannhake, E. W., Canning, B. J. et al., The effects of ozone on immune function. Environ. Health Perspect. 103, 77 (1995)
8. Canning, B. J., Hmieleski, R. R., Spannhake, E. W. et al., Ozone reduces murine alveolar and peritoneal macrophage phagocytosis: The role of prostanoids. Am. J. Physiol. 261, L277 (1991)
9. Chatterjee, D., Mukherjee, S. K., Destruction of phagocytosis-suppressing activity of aflatoxin B1 by ozone. Lett. Appl. Microbiol. 17, 52 (1993)
10. León, O. S., Menéndez, S., Merino, N. et al., Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediat. Inflamm. 7, 289 (1998)
11. Candelario-Jalil, E., Mohammed-Al-Dalain, S., León, O. S. et al., Oxidative preconditioning affords protection against carbon tetrachloride- induced glycogen depletion and oxidative stress in rats. J. Appl. Toxicol. 21, 122 (2001)
12. Peralta, C., León, O. S., Xaus, C. et al., Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free. Rad. Res. 31, 191 (1999)
13. Barber, E., Menéndez, S., Leon, O. S. et al., Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischemia. Mediat. Inflamm. 8, 37 (1999)
14. Hernández, F., Menéndez, S., Wong, R., Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free. Rad. Biol. Med. 19, 115 (1995)
15. Bocci, V., Does ozone therapy normalize the cellular redox balance? Med. Hypotheses. 46, 150 (1996)
16. Romero, A., Menéndez, S., Gómez, M. et al., Ozone therapy in the advanced stages of arteriosclerosis obliterans. Angiología 45, 146 (1993)
17. Bocci, V., Biological and clinical effects of ozone. How ozone therapy a future in medicine? Br. J. Biomed. Sci. 56, 270 (1999)
18. Schulz, S., Zamora, Z. B., Mutters, R. et al., Repetitive pneumoperitoneum with ozonized oxygen as a preventive in lethal polymicrobial sepsis in rats. Eur. Surg. Res. 35, 26 (2003)
19. Aggawal, B. B., Kohr, W. J., Hass, P. E. et al., Human tumor necrosis factor production purification and characterization. J. Biol. Chem. 260, 2345 (1985)
20. Murry, C. E., Richard, V. J., Reimer, K. A. et al., Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res. 66, 913 (1990)
21. Neschis, D. G., Safford, S. D., Raghunath, P. N. et al., Thermal preconditioning before rat arterial balloon injury: limitation of injury and sustained reduction of intimal thickening. Thromb. Vasc. Biol. 18, 120 (1998)
22. Riepe, M. W., Ludolph, A. C., Chemical preconditioning: a cytoprotective strategy. Mol. Cell. Biochem. 174, 249 (1997)
23. Peralta, C., Hotter, G., Closa, D. et al., Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 25, 934 (1997)
24. Peralta, C., Closa, D., Xaus, C. et al., Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 28, 768 (1998)
25. Peralta, C., Xaus, C., Battrons, R. et al., Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Rad. Res. 33, 595 (2000)
26. Klosterhalfen, B., Bhardwaj, S., Septic shock. Gen. Pharmacol. 31, 25 (1998)